Open access
Open access
Powered by Google Translator Translator

Hepatology

Portopulmonary hypertension: current developments and future perspectives.

21 Nov, 2022 | 14:20h | UTC

Portopulmonary hypertension: Current developments and future perspectives – Liver Research 

Related: Pulmonary complications in liver disease – Intensive Care Medicine (free) 

Related Reviews:  

Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment – Liver International 

Pulmonary complications of hepatic diseases – World Journal of Gastroenterology 

Pulmonary Vascular Complications of Liver Disease – American Journal of Respiratory and Critical Care Medicine 

 


Phase 2b RCT | Efficacy and safety of Bepirovirsen in chronic Hepatitis B infection.

11 Nov, 2022 | 13:44h | UTC

Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Retrospective Cohort Study | Perinatal outcomes associated with ICP in twin pregnancies were worse than singletons.

11 Nov, 2022 | 13:36h | UTC

Perinatal outcomes associated with ICP in twin pregnancies were worse than singletons: an almost 5-year retrospective cohort study – BMC Pregnancy and Childbirth

 


M-A | Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis.

8 Nov, 2022 | 11:58h | UTC

Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis – Frontiers in Pharmacology

 


Review | Determining prognosis of alcoholic liver disease and alcoholic hepatitis.

4 Nov, 2022 | 13:17h | UTC

Determining Prognosis of ALD and Alcoholic Hepatitis – Journal of Clinical and Experimental Hepatology 

 


ERAS Guidelines for perioperative care for liver surgery.

1 Nov, 2022 | 12:16h | UTC

Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022 – World Journal of Surgery

Related:

Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

 


Review | Management of NAFLD in primary care settings.

27 Oct, 2022 | 12:24h | UTC

Management of NAFLD in primary care settings – Liver International

Related:

Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – Zeitschrift für Gastroenterologie

AGA Clinical Practice Update | Diagnosis and management of nonalcoholic fatty liver disease in lean individuals.

Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group – The Lancet Gastroenterology & Hepatology (free registration required)

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association – Arteriosclerosis, Thrombosis, and Vascular Biology

Advancing the global public health agenda for NAFLD: a consensus statement – Nature Reviews Gastroenterology & Hepatology

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease – Gastroenterology

Non-alcoholic fatty liver disease: A patient guideline – JHEP Reports

 

Commentary on Twitter

 


AHA Scientific Statement | Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates.

24 Oct, 2022 | 14:11h | UTC

Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association – Circulation (PDF)

Top Things to Know: Emerging Evidence on Coronary Heart Disease (CHD) Screening in Kidney and Liver Transplantation Candidates – American Heart Association

Commentary: Trials and Tribulations of Cardiac Screening Asymptomatic Kidney and Liver Transplant Candidates – American Heart Association

 


Case-control study | Post-paracentesis ascitic fluid leak in patients with cirrhosis of liver and its management.

21 Oct, 2022 | 12:57h | UTC

Post-Paracentesis Ascitic Fluid Leak in Patients with Cirrhosis of Liver and its Management: A Prospective Study – Journal of Clinical and Experimental Hepatology

 


M-A of RCT | Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis.

20 Oct, 2022 | 12:25h | UTC

Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis – Journal of Hepatology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Choosing Wisely | Top five list of procedures to avoid in the treatment of viral hepatitis.

7 Oct, 2022 | 14:22h | UTC

Choosing Wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: a position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

 


Baveno VII – Renewing consensus in portal hypertension.

7 Oct, 2022 | 14:17h | UTC

Baveno VII – Renewing consensus in portal hypertension – Journal of Hepatology

 


RCT | Trientine tetrahydrochloride noninferior to penicillamine for maintenance therapy in Wilson disease.

7 Oct, 2022 | 14:10h | UTC

Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Review | Alcohol and acute-on-chronic liver failure.

4 Oct, 2022 | 14:33h | UTC

Alcohol and Acute-on-Chronic Liver Failure – Journal of Clinical and Experimental Hepatology

Related:

Acute-on-Chronic Liver Failure Clinical Guidelines – American Journal of Gastroenterology

Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU

Supplement | The role of liver transplantation in acute-on-chronic liver failure.

 


Review | Acute kidney injury in patients with liver disease.

3 Oct, 2022 | 13:56h | UTC

Acute Kidney Injury in Patients with Liver Disease – Clinical Journal of the American Society of Nephrology

 

Commentary on Twitter

 


Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients.

28 Sep, 2022 | 13:37h | UTC

Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients – Critical Care

 


Practice Guidance | A multidisciplinary approach to the diagnosis and management of Wilson Disease.

27 Sep, 2022 | 13:13h | UTC

A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases – Hepatology

 


Review | Adrenal insufficiency in cirrhosis.

22 Sep, 2022 | 12:59h | UTC

Adrenal Insufficiency in Cirrhosis – Journal of the Endocrine Society

 


Nutrition assessment and management in patients with cirrhosis and cognitive impairment: a comprehensive review of literature.

19 Sep, 2022 | 12:29h | UTC

Nutrition Assessment and Management in Patients with Cirrhosis and Cognitive Impairment: A Comprehensive Review of Literature – Journal of Clinical Medicine

Commentary: Review Outlines Nutrition Assessment, Management in Patients With Cirrhosis – AJMC

 


Update | Management of hepatorenal syndrome in liver cirrhosis.

19 Sep, 2022 | 12:27h | UTC

Management of hepatorenal syndrome in liver cirrhosis: a recent update – Therapeutic Advances in Gastroenterology

 


German guidelines on non-alcoholic fatty liver disease.

15 Sep, 2022 | 13:07h | UTC

Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – Zeitschrift für Gastroenterologie

Related:

AGA Clinical Practice Update | Diagnosis and management of nonalcoholic fatty liver disease in lean individuals.

Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group – The Lancet Gastroenterology & Hepatology (free registration required)

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association – Arteriosclerosis, Thrombosis, and Vascular Biology

Advancing the global public health agenda for NAFLD: a consensus statement – Nature Reviews Gastroenterology & Hepatology

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease – Gastroenterology

Non-alcoholic fatty liver disease: A patient guideline – JHEP Reports

 


Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts.

13 Sep, 2022 | 13:13h | UTC

Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts – Intensive Care Medicine

 

Commentary on Twitter

 


M-A | Combination therapy with rifaximin and lactulose in hepatic encephalopathy.

11 Sep, 2022 | 22:33h | UTC

Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis – PLOS One

Commentary: Rifaximin Plus Lactulose Linked to Greater Effectiveness, Decreased Mortality in HE – AJMC

 


Nonalcoholic fatty liver disease: review of management for primary care providers.

5 Sep, 2022 | 14:18h | UTC

Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers – Mayo Clinic Proceedings

 


Systematic Review | Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

5 Sep, 2022 | 14:13h | UTC

Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease – Cochrane Library

Summary: How accurate are contrast-enhanced ultrasound scans for detecting hepatocellular carcinoma? – Cochrane Library

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.